| Sanquin Pharmaceutical Services is a dedicated and certified Contract Service Organisation (CSO) offering a broad array of services aimed at the development of biopharmaceuticals for both in vivo and in vitro application such as monoclonal antibodies and r-DNA proteins. As part of a larger organisation (Sanquin employs more than 2800 people), financial stability and a broad field of expertise are coupled with the flexibility and dedication of a smaller company, providing you with a trustworthy partner aimed at meeting your goals and deadlines.
Our multi-purpose plant and supporting laboratories are located in Amsterdam, very close to Schiphol Airport, and are designed to meet the current regulatory requirements for the production and safety testing of biopharmaceuticals. For this purpose, Sanquin Pharmaceutical Services holds a GMP-license for its production activities, a GCLP-license for all QC and safety tests, as well as a GLP accreditation for their viral/prion validation services.
Sanquin Pharmaceutical Services has more than 15 years experience in designing production strategies and scaling up of production of biopharmaceuticals using state-of-the-art fermentation and purification techniques, including potent virus inactivation and removing steps. In contrast to what many other contract manufacturers offer, Sanquin Pharmaceutical Services can also provide you with a broad expertise in the field of biosafety testing and other similar supportive services, such as the process validation for demonstrating reduction of viruses and/or prions during purification and stability and formulation studies. |